Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MET-FINGER trial of metformin plus lifestyle intervention for dementia prevention
2022-500438-27-01Phase 2Authorised
- Sponsor
- Imperial College London
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in confusion and Dementia comparing Metformin + lifestyle intervention with Placebo + lifestyle intervention (2 arms). Primary endpoint: Extended Neuropsychological Test Battery composite z-score. Planned start Jun 2023; status: authorised.
02
Drugs
metformin
03
Conditions
confusionDementia
Beyond the preview
Go deeper on 2022-500438-27-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500438-27-01.